Lv4
432 积分 2026-01-15 加入
Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy
25天前
已完结
Minor Changes in Response Modules Leading to a “U-Shaped” Conversion Rate of Docetaxel Prodrug Nanoassemblies
25天前
已完结
Trisulfide bond–mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity
25天前
已完结
Tetrasulfide bond boosts the anti-tumor efficacy of dimeric prodrug nanoassemblies
26天前
已完结
Disulfidptosis Nanoinducer Interrupts Tumor Metabolic Privilege to Boost Sustained Immunotherapy
1个月前
已完结
Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment
1个月前
已完结
Optimizing the stable doxorubicin prodrug nanocomplex for efficient and selective cancer therapy
1个月前
已完结
Tumor-Directed Disulfidptosis via Spatiotemporally Controlled Copper Bioorthogonal Activation
1个月前
已完结
Hypoxia-Activated PEGylated Paclitaxel Prodrug Nanoparticles for Potentiated Chemotherapy
3个月前
已完结
Hypoxia-activated paclitaxel prodrugs enable PD-L1 degradation to potentiate cancer chemo-immunotherapy
3个月前
已完结
皖公网安备34019202002308
